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Abstract
Background: Ensuring rapid access to high quality sexual health services is a key public health objective, both in the United
Kingdom and internationally. Internet-based testing services for sexually transmitted infections (STIs) are considered to be a
promising way to achieve this goal. This study will evaluate a nascent online STI testing and results service in South East London,
delivered alongside standard face-to-face STI testing services.
Objective: The aim of this study is to establish whether an online testing and results services can (1) increase diagnoses of STIs
and (2) increase uptake of STI testing, when delivered alongside standard face-to-face STI testing services.
Methods: This is a single-blind randomized controlled trial. We will recruit 3000 participants who meet the following eligibility
criteria: 16-30 years of age, resident in the London boroughs of Lambeth and Southwark, having at least one sexual partner in
the last 12 months, having access to the Internet and willing to take an STI test. People unable to provide informed consent and
unable to read and understand English (the websites will be in English) will be excluded. Baseline data will be collected at
enrolment. This includes participant contact details, demographic data (date of birth, gender, ethnicity, and sexual orientation),
and sexual health behaviors (last STI test, service used at last STI test and number of sexual partners in the last 12 months). Once
enrolled, participants will be randomly allocated either (1) to an online STI testing and results service (Sexual Health 24) offering
postal self-administered STI kits for chlamydia, gonorrhoea, syphilis, and HIV; results via text message (short message service,
SMS), except positive results for HIV, which will be delivered by phone; and direct referrals to local clinics for treatment or (2)
to a conventional sexual health information website with signposting to local clinic-based sexual health services. Participants
will be free to use any other interventions or services during the trial period. At 6 weeks from randomization we will collect
self-reported follow-up data on service use, STI tests and results, treatment prescribed, and acceptability of STI testing services.
We will also collect objective data from participating STI testing services on uptake of STI testing, STI diagnoses and treatment.
We hypothesise that uptake of STI testing and STI diagnoses will be higher in the intervention arm. Our hypothesis is based on
the assumption that the intervention is less time-consuming, more convenient, more private, and incur less stigma and embarrassment
than face-to-face STI testing pathways. The primary outcome measure is diagnosis of any STI at 6 weeks from randomization
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and our co-primary outcome is completion of any STI test at 6 weeks from randomization. We define completion of a test, as
samples returned, processed, and results delivered to the intervention and/or clinic settings. We will use risk ratios to calculate
the effect of the intervention on our primary outcomes with 95% confidence intervals. All analyses will be based on the
intention-to-treat (ITT) principle.
Results: This study is funded by Guy’s and St Thomas’ Charity and it has received ethical approval from NRES Committee
London-Camberwell St Giles (Ref 14/LO/1477). Research and Development approval has been obtained from Kings College
Hospital NHS Foundation Trust and Guy’s and St Thomas’ NHS Foundation Trust. Results are expected in June 2016.
Conclusions: This study will provide evidence on the effectiveness of an online STI testing and results service in South East
London. Our findings may also be generalizable to similar populations in the United Kingdom.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 13354298;
http://www.isrctn.com/ISRCTN13354298 (Archived by WebCite at http://www.webcitation.org/6d9xT2bPj)
(JMIR Res Protoc 2016;5(1):e9)   doi:10.2196/resprot.4094
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Introduction
Sexually transmitted infections (STIs) are an important cause
of morbidity and mortality worldwide, and a key indicator of
sexual ill health. Globally, incident cases of curable STIs
(chlamydia, gonorrhoea, syphilis, and trichomonas vaginalis)
rose from 448.3 million in 2005 to 498.9 million in 2008 [1].
While global incidence rates of HIV infection are on the decline,
prevalence remains significant: UNAIDS estimated 2.3 million
new HIV infections in 2012 and that 35.3 million people were
living with HIV [2]. Moreover, HIV/AIDs represents 3.4% of
the total global disease burden and is the seventh leading cause
of all disability-adjusted life years worldwide [3].
In England, 448,422 new STI diagnoses were made in 2012,
with higher rates recorded among young heterosexuals, men
who have sex with men, and some black and ethnic minority
groups [4]. Importantly, the patterning of STIs reflects stark
health inequalities. A recent probability sample survey found
that men and women from the most deprived areas of Britain
had greater odds of testing positive for chlamydia (the most
common STI) than those from wealthier areas (men, adjusted
OR 3.42 (95%CI, 1.28-9.16), P=.003; women, adjusted OR
4.01(95%CI, 1.67-9.63), P=.008) [5].
Increasing diagnoses of untreated STIs is a key public health
objective, both in the United Kingdom and internationally, to
reduce onward transmission of infection and prevent long term
health complications [6]. Increasing access to HIV testing and
ensuring early diagnoses of HIV in high prevalent areas is of
particular concern. In 2013, in the United Kingdom, it was
estimated that a quarter of those living with HIV were unaware
that they were infected and 42% of those diagnosed with HIV
were diagnosed late, after the point at which treatment should
have begun [7].
Internet-based STI testing is considered a promising means for
increasing access to STI testing and reaching high-risk groups
[8]. There are a number of models for Internet-based STI testing.
For the purposes of this study we focus on a model which
enables users to order a test kit online, take self-administered
samples in their home, return test samples to a laboratory and
receive their results via SMS text messaging (short message
service, SMS), email or phone call. As far as we are aware,
there have been no experimental studies to demonstrate the
effectiveness of Internet-based testing services compared to
standard face-to-face clinical pathways.
Observational studies have been encouraging, reporting high
STI positivity among service users and reaching populations
with a combination of both sociodemographic and behavioral
risk factors. In the United States, Ladd and colleagues found
that out of 205 rectal samples ordered and returned by women
using the “iwantthekit” website between January 2009 and
February 2011, 18.5% were positive for at least one STI [9].
The majority of women in the sample were single (91.2%),
young (mean age 25.8 years) and of African-American ethnicity
(50.0%). Half had never used condoms for rectal sex (48.7%).
A study with male users of the same website found that of 501
STI kits returned by men over the age of 14, between September
2006 and May 2009, 21% tested positive for chlamydia,
gonorrhoea or trichomonas vaginalis [10]. The majority of users
were young (median age 24.5 years), single (84%), and either
white (47%) or black ethnicity (45%). While these studies are
promising, sample sizes have been small and no comparison
has been made with users of face-to-face pathways.
In the United Kingdom there is limited evidence on
Internet-based STI testing. One descriptive study reported trends
in chlamydia testing among 15-24 year olds. It found that
Internet tests, which have not been widely promoted, represented
5% of all tests within the National Chlamydia Screening
Programme (NCSP) between 2006 and 2010 [11]. A higher
proportion of Internet tests were positive compared to tests
conducted in general practice services (7.6% vs 5.6%) but
slightly lower than in community-based sexual and reproductive
health services (7.6% vs 8.2%). Compared to testers in
face-to-face settings, a higher proportion of Internet testers were
men, of white ethnicity, and in the upper age group (20-24
years).
Recent exploratory qualitative studies with young people in the
United Kingdom suggest that Internet or mobile applications
of sexual health services are likely to be acceptable to this
population, due to ease and convenience. Privacy, trust and
credibility of websites or apps were highlighted as important
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considerations for service development [12,13]. However, there
is some uncertainty on whether Internet services can reach
marginalized populations. In Scotland, Lorimer and McDaid
[14] found that young men from more deprived areas seemed
more disconnected from Internet technology and stated a
preference for face-to-face services. This echoes findings from
analysis of chlamydia testing data from England (discussed
earlier), which found that a higher proportion of tests conducted
in face-to-face services (GP and SRH clinics) were from more
deprived areas, compared to Internet tests [11].
Given the limited evidence base it is difficult to draw
conclusions on the effectiveness of Internet-based pathways in
diagnosing a range of STIs compared to face-to-face service
pathways.
Sexual Health 24 (SH:24) is an innovative Internet-based sexual
health service that aims to improve access to sexual health
services in the London boroughs of Southwark and Lambeth
by addressing both supply and demand side barriers to care.
Southwark and Lambeth have some of the highest rates of STIs
in England, as well as high rates of teenage pregnancy and
abortion [15]. Current face-to-face services are unable to meet
demand with the result that many people are turned away from
services.
In November 2014, SH:24 launched its first online product
(minimal viable product 1) - an online STI testing and results
service allowing users to order free postal STI kits, receive their
results by SMS text messaging (or by phone in the event of a
positive HIV result), and be referred on to specialist sexual
health clinics for treatment. Over the course of this 4 year
project, SH:24 will build in complexity, gradually adding
increasing layers of functionality to the website, such as
telephone support services and contraceptive services. SH:24
will be fully embedded within local sexual health economies
ensuring that care pathways are integrated with clinical and
other local services: for example by ensuring that users with
acute STIs are signposted to face-to-face clinical care.
As an untested intervention, SH:24 has implications for the
commissioning of sexual health services not only in London
but also nationally. In line with national and international quality
frameworks, SH:24 will be evaluated using a variety of data
sources and methodologies to assess whether it delivers a safe,
effective, patient-centered, timely, efficient, and equitable
service [16,17]. This study will focus on establishing whether
SH24 delivers an effective Internet-based STI testing and results
service compared to face-to-face STI testing services, thus
contributing to the international evidence base in this field.
Methods
Study Design
We will carry out a randomized controlled trial (Figure 1).
Participants will be randomly allocated either (1) to a sexual
health website (SH:24) offering free postal STI kits for
chlamydia, gonorrhoea, syphilis and HIV, results via SMS text
messaging (positive results for HIV will be delivered by phone),
and direct referrals to clinic-based treatment options; or (2) to
a conventional sexual health information website with
signposting to local clinic-based sexual health services.
Participants will be free to use any other service or intervention
during the trial period.
Eligibility
Participants will be eligible if they are between 16 and 30 years
of age, resident in the London boroughs of Lambeth and
Southwark, sexually active (at least one sexual partner in the
last 12 months), willing to take an STI test, and have access to
the Internet (owner of a mobile phone or able to access a laptop,
tablet, personal computer in their own home). Participants will
be excluded if they are unable to read in English as the websites
will be in English. Those unable to give informed consent, such
as people with severe learning difficulties, will also be excluded.
Recruitment and Consent
This study is being conducted in community settings in the
boroughs of Lambeth and Southwark in South East London.
The study coordinator, together with a team of research
assistants, will approach community networks, organizations,
and institutions such as further education colleges, universities,
patient groups, sexual health advocacy groups, sports centers,
entertainment and leisure venues and major employers to recruit
participants. We will also utilize social media sites popular
among our study population. These will include Facebook,
Twitter, and dating applications for gay men such as Scruff and
Grindr.
After potential participants have been assessed for their
eligibility, they will be provided with detailed verbal and written
information about the study, and given the opportunity to ask
any questions. If the participant agrees to participate, we will
ask them to provide consent via the trial website (eg, using a
mobile phone) or via paper-based forms. If potential participants
would like more time to consider their involvement, we will
give them the contact details of the study coordinator so that
they can talk through any queries or doubts. Potential
participants will also be able to access the study website
independently, for example via social media sites.
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Figure 1. Consolidated Standards of Reporting Trials (CONSORT) flow chart.
Allocation
Participants will be asked to enter baseline data directly onto
the trial website or using paper-based forms. After baseline
information has been submitted, an independent computer-based
randomization program will generate a unique research number
and allocate participants to either the intervention or control
group. Participants will be sent a SMS text message with the
URL of their allocation.
We will allocate by minimization, taking into account gender
(male, female), age (16-19, 20-24, 25-30), number of sexual
partners (1, 2+) and sexual orientation (men who have sex with
men [MSM], all other groups), where all factors have equal
weight in determining marginal imbalance. To introduce a
random element, allocation will be weighted toward the
underrepresented group using a probability of .8. In all other
instances, participants will be allocated in a 1:1 ratio.
Due to the nature of the intervention, participants will know to
which arm they have been allocated. Laboratory staff carrying
out STI tests will process the tests as per routine care, and will
be unaware that samples are linked to a randomized controlled
trial. Researchers assessing the outcomes will be blind to the
treatment allocation.
Intervention Group
Through a design-led and user-centered approach, SH:24 has
created an appropriate Internet-based sexual health service with
the aim of improving access to sexual health services in the
boroughs of Southwark and Lambeth.
Participants in the intervention group will be directed to a
website which will offer them: sexual health risk assessment;
the opportunity to order self-administered sample collection
kits for HIV, chlamydia, syphilis, gonorrhoea; results given by
SMS text message and by phone (positive HIV result only);
direct referral to local clinics for treatment; health promotion
information; signposting to clinic and other social services.
Participants who test positive for chlamydia, syphilis or
gonorrhoea infection will be sent a SMS text message with their
result and details of local sexual health clinics where they will
be able to obtain treatment. Participants who test positive for
HIV will be informed by phone by a health professional.
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Control Group
Participants in the control group will be directed to a sexual
health information website with signposting to clinic-based
services. These include the Camberwell Sexual Health Centre,
the Burrell Street Sexual Health Centre, the Lloyd Clinic and
a range of local community-based sexual and reproductive health
services in Lambeth and Southwark, where they can obtain an
STI test in person. The information website will provide the
address, contact details, and location of the clinics (via a google
map image), alongside the URL link to the clinic website.
All participants will be free to use any other services or
interventions during the trial period.
Outcomes
Our primary outcomes will be the proportion of participants
diagnosed with at least one STI in each arm at 6 weeks from
randomization, and the proportion of participants who complete
at least one STI test in each arm at 6 weeks from randomization.
The secondary outcomes are listed in Textbox 1.
Textbox 1. Secondary outcomes.
• The proportion of STI tests that are positive in each arm
• The proportion of participants who are prescribed treatment in each arm
• Time from randomization to completion of an STI test in each arm
• Time from randomization to treatment in each arm
• Time from diagnosis to treatment in each arm
• The proportion of the intervention group who agree that Internet-based STI testing is acceptable
• The proportion of the intervention group who adhere to the prescribed Internet-based testing pathway, without seeking additional support from
face-to-face services
Data Collection
Eligibility data will include age, postal code, independent access
to the Internet (owner of mobile phone or access to tablet, laptop
or computer at home), at least one sexual partner in the last 12
months, willingness to take an STI test.
Participants will be asked to enter their baseline data directly
onto the trial website or using paper-based forms. We will
collect the following: contact details including first name,
surname, main mobile number, email address, and primary
postal address; demographic data including date of birth, gender,
ethnicity, and sexual orientation; sexual health behaviors
including last STI test, service used at last STI test, and number
of sexual partners in the last 12 months
Self-reported follow up data at 6 weeks will be collected by
post or online, according to the preference of participants. We
will assess whether Internet-based testing was acceptable to
participants and collect data on service use, STI tests and results,
and whether treatment was prescribed. We will also collect
objective data on STI tests, results, and treatment from SH:24
and local sexual health services, with participants’prior consent.
Lab Processing
The Doctors Laboratory (TDL) will process all returned samples
for the intervention group and the results will be captured by
SH:24 data systems. Samples taken in face-to-face settings will
be processed as per routine care. The study coordinator will
contact the local services and SH:24 to obtain participants’ test
results and treatment details, with prior consent. These data will
be anonymized and uploaded into the secure trial website.
Follow-Up
We will utilize evidence-based methods identified in systematic
reviews to minimize losses to follow up [18]. These include
providing incentives to all participants, contacting respondents
prior to sending questionnaires and contacting nonresponders
using phone call, texting, email, and post. The research team
will verify participant addresses at enrolment or shortly after,
and attempt to contact participants who have provided an
incomplete or unknown address.
To maximize participation and response rates we will provide
an incentive (such as a lollipop or chocolate) at enrolment and
an unconditional incentive of £5 at 6 weeks when we send out
the follow-up questionnaire. Participants will then receive a
further £5, on receipt of their completed questionnaires. They
will be informed of the incentives at enrolment. Our incentives
will not exceed a monetary value of £15 per participant.
Sample Size
The study is powered for the first of our primary outcome
measures which is the proportion of participants diagnosed with
at least one STI in each arm. Two factors determine the number
of participants needed for this trial: the estimated proportion of
participants with an STI and the size of the treatment effect.
Our estimates are based on the following data:
The Greenwich sexual health service has demonstrated a 50%
return rate among users who order test kits online (personal
communication Dr David Pinson, Health Improvement Principal,
Royal Borough of Greenwich). Eligibility for this study is
restricted to people who are willing to take an STI test. However,
not all of those allocated to the intervention group are likely to
order a test kit. We estimate that 30% will not complete this
first step. Among the 70% who order a kit, we assume that 50%
will return the kit for analysis, based on the Greenwich data.
Following these assumptions, 35% of the intervention group
are likely to complete an STI test.
There are no available data which would give us an estimate of
the likely numbers that will get tested in the control group.
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However, we assume that far fewer people (10%) are likely to
seek a test in clinic-based settings.
Chlamydia is the most commonly diagnosed STI of the four
STIs of interest in this study both at the national level (England)
and at the local authority level (Lambeth and Southwark) [4,15].
We based our prevalence estimates on the proportion of positive
chlamydia tests among 15-24 year olds in general practice
settings in Lambeth and Southwark, which was 6% in 2012
[19].
We based our estimated losses to follow up on previous eHealth
studies in the United Kingdom which have achieved 90% follow
up [20].
A sample size of 3000 would have 90% power (two-sided
alpha=5%) to detect a relative risk of 3.5, (2.1% risk of diagnosis
in the intervention group vs 0.6% risk of diagnosis in the control
group), allowing for 10% losses to follow up. This equates to
10% of the control group being tested, with a 6% probability
of infection as in general practice settings and 35% of the
intervention tested with a 6% probability of infection as in
general practice settings.
With regard to our co-primary outcome measure, with 3000
participants we would have 99% power (two-sided alpha=5%)
to detect an absolute difference of 25% between the proportion
of participants who complete a test in the intervention group
versus the proportion who complete a test in the control group
(35% versus 10%).
Statistical Methods
The analysis of data will adhere to the prespecified statistical
analysis plan outlined below. The analyses of the co-primary
outcomes are described in detail; analyses for other outcomes
follow the same principles unless otherwise specified.
There are no planned interim analyses and so no rules for
stopping early. Analyses comparing the interventions will follow
the ITT principle as far as possible [21]. Analyses will include
participants with no missing outcome data in their randomized
groups. Any estimate described below will be accompanied by
95% confidence intervals.
The primary analysis of the first co-primary outcome (STI
diagnosis) will estimate the proportion of STI diagnoses for the
SH:24 vs conventional sexual health services via a risk ratio.
Treatment allocation balances gender, age, number of sexual
partners in the last 12 months, and sexual orientation, and these
need to be reflected in the analysis. This will be done by
weighting on the inverse propensity score (estimated by logistic
regression) to reduce the variance of estimates and obtain
confidence intervals of the correct width [22].
Some outcome data are expected to be missing. Missing data
may occur if participants do not complete a 6-week follow-up
questionnaire and attend a different sexual health service (ie,
not a local clinic or SH:24) . The principle analysis will assume
that the distribution of STI diagnoses among these participants
is identical to those with observed data, conditional on
propensity scores–missing at random–and so will be based on
the weighted analysis of the complete cases. Sensitivity analyses
assuming departures from missing at random will proceed via
multiple imputation of outcome, using inverse probability
weighting on the estimated propensity score and with allocated
group as the only covariate. Assuming “missing not at random”
mechanisms, the odds of STI diagnoses for missing participants
will be varied to be ¼, ½, 2 and then 4 times larger than in the
missing at random (MAR) analysis. This will be done in a
factorial manner, separately for each arm. We judge these
fractions to be reasonable, though a value of ¼ in one arm and
4 in the other (or vice versa) is at the boundary of what is
plausible. The risk difference (rather than ratio), weighted by
the inverse propensity score, and the proportion of STI diagnoses
in each arm will also be presented. Finally, the proportion of
STI tests taken that are positive will be summarized by arm,
though no comparison of the groups will be given because this
analysis excludes individuals based on a variable that will be
heavily influenced by randomization.
The primary analysis of the second co-primary outcome
(completion of an STI test) and secondary outcome (prescribed
treatment) will follow the same principles as above. Again, the
risk ratio, risk difference, and proportions in each arm will be
reported.
The time from randomization to (1) test completion and (2)
treatment are of interest. Therefore, for each measure we will
estimate the restricted-mean survival time (RMST) in each arm,
setting the restricted mean time t*=6 weeks for time to test and
t*=3 months for time to treatment. This will be estimated from
a “3df/1df” Royston-Parmar model and the difference in
restricted-mean survival time estimated [23]. The median
survival time from diagnosis to treatment in each arm will also
be summarized. No comparison will be made between groups
as this analysis excludes individuals based on a variable (STI
diagnosis) that is heavily influenced by randomization.
For the SH:24 group, the proportion of participants who deem
Internet-based testing to be acceptable will be summarized, as
will the proportion who adhere to the SH:24 testing pathway.
It is possible that differences between groups will vary according
to age, level of deprivation, sexuality, ethnicity, and gender.
Subgroup analyses will be done for these characteristics and
interaction tests will be performed. These will have low impact
as we anticipate any interactions will be small. Further, these
analyses will be regarded strictly as hypothesis-generating.
Ethical Arrangements
Informed Consent
All participants recruited into the trial will be provided with
information about the study (online or in hard copy) and given
the opportunity to ask questions and clarify queries at the time
of recruitment and subsequently with the study coordinator by
email or by phone. The recruiting staff will check that
participants are aware that consenting to participate means that
they will be encouraged to undertake an STI test.
Participants’ Rights
Participants will be able to contact the trial co-ordinating center
at Kings College London by email or by phone with any queries
or doubts for the duration of the trial. If they request to be
withdrawn from the study their status will be changed to
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“withdrawn” on the study website and they will be excluded
from participant lists for follow up.
Personal details will be stored on a password protected computer
held on a secure server at Kings College London. This
information will be stored separately from any anonymized
research data, and will be deleted at the end of the study.
Participants in the intervention arm who report symptoms of
STIs will be advised to see a health professional in a clinic-based
setting. If they wish to continue with the Internet-testing
pathway they will be allowed to do so. Participants in the
intervention arm will be informed about any positive results for
chlamydia, gonorrhoea, and syphilis by SMS text message and
they will be texted information of local clinics where they can
receive treatment. Participants who test positive for HIV will
be informed by telephone by a trained health professional and
will be referred on to specialist HIV services.
Participants’ Safety
The intervention provides an opportunity to obtain a postal STI
kit, notification of STI diagnoses, and opportunities for STI
treatment. It is unlikely to cause any harmful effects. Participants
who lack privacy in their home or participants who are in
abusive interpersonal relationships may risk possible
consequences if they participate in Internet-based STI testing.
However, this risk will be minimized as we will ensure that at
recruitment participants have sufficient privacy to participate
in the trial. Furthermore, the website can be accessed via devices
such as mobile phones and postal test kits will be sent out in
packages that do not have any identifying features. Other large
scale studies using Internet-based testing have not reported any
related safety concerns [24]. The intervention website will also
provide clear signposting to counselling services for violence
as well as contraception and abortion services.
All sexual health services participating in this trial routinely
deliver test results via SMS text message. There is a small risk
that friends and partners may see participants’ results if phones
are shared. However, as in routine care, if participants are
concerned about their privacy they can opt to receive their
results via different methods (eg, via post). The intervention
delivers the results via SMS text message (except in the case
of a positive result for HIV, which is delivered via phone).
However, this is made very clear on the website and participants
can choose not to order an STI test kit online, if they are
concerned about their privacy.
Retention of Trial Documentation
We will retain the trial documentation for 10 years.
Results
By April 21, 2015, 1405 participants were randomized. We are
currently recruiting and a timeline of our trial is included in
Table 1.
Table 1. Trial timeline.
TasksTimeline
Trial setupMonths 1-6 (April-September 2014)
Intervention website user tested and finalized (to be developed and finalized
by SH:24)
Completed and user tested trial database and randomization system
Recruitment strategy designed and completed
By month 6 (September, 2014)
Recruitment to the trial completedBy month 16 (July, 2015)
All follow up completedBy month 22 (January 2016)
Data cleaned, trial database closedBy month 24 (March, 2016)
Analysis of trial results completed
Paper submitted for publication
By month 27 (June, 2016)
Discussion
This trial will provide a robust and rigorous evaluation of a
nascent online STI testing service in an area of South East
London, characterized by poor levels of sexual health relative
to the rest of the country. It will assess the added contribution
of this service with respect to two distinct but interrelated
outcomes: diagnoses of STIs and uptake of STI testing.
We envision that our findings will be highly policy-relevant
and will be well-placed to inform decision-making for the
effective commissioning and delivery of STI testing services
in London. Our findings may also be generalizable to similar
populations in the United Kingdom.
To our knowledge, this is the first RCT of an Internet-based
testing service, which makes a direct comparison with standard
face-to-face care. The findings from this study will therefore
make a timely contribution to the international evidence base
in this field.
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